Thomas Renne

Title: Thomas Renne: Innovator in Anti-Thrombotic Treatments

Introduction

Thomas Renne is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of diseases linked to pathological kinin formation. His innovative work focuses on the development of therapies that target thrombus formation, which is crucial for improving patient outcomes in various medical conditions.

Latest Patents

Thomas Renne holds a patent for the "Treatment of diseases linked to pathological kinin formation." This invention relates to the use of at least one antibody and/or one inhibitor for inhibiting factor XII. It aims to prevent the formation and/or stabilization of three-dimensional thrombi. Additionally, the patent discusses a pharmaceutical formulation and the use of factor XII as an anti-thrombotic target. He has 1 patent to his name, showcasing his innovative approach to addressing complex medical challenges.

Career Highlights

Renne is currently associated with CSL Behring GmbH, a company known for its commitment to developing innovative therapies for patients with serious and rare diseases. His work at CSL Behring has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research that has the potential to change lives.

Collaborations

One of his notable collaborators is Bernhard Nieswandt. Together, they have worked on advancing research in the area of thrombus formation and its implications for patient care.

Conclusion

Thomas Renne's contributions to the field of anti-thrombotic treatments highlight his dedication to medical innovation. His patent and ongoing work at CSL Behring reflect his commitment to improving health outcomes for patients worldwide.